A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jhep.2021.01.013
PubMed Identifier: 33484775
Publication URI: http://europepmc.org/abstract/MED/33484775
Type: Journal Article/Review
Volume: 74
Parent Publication: Journal of hepatology
Issue: 6
ISSN: 0168-8278